IgNS: Advancing Education, Research, and Patient Care in Ig Therapy

Immunoglobulin National Society.

Access to safe and effective immunoglobulin (Ig) therapy can be life-changing for patients living with rare or chronic illnesses. The Immune Globulin National Society (IgNS) plays an important role in advancing education, research, and best practices for Ig therapy, making sure patients receive high-quality care in the comfort of their homes. Through conferences, clinical guidelines, and professional development, IgNS helps clinicians provide the most effective and compassionate care possible.  

IgNS Supports Ig Industry Professionals 

IgNS provides continuing education and resources for infusion nurses, specialty pharmacists, and clinicians, helping them stay current with the latest findings in Ig therapy. IgNS helps healthcare professionals by providing: 

  • On-demand webinars and networking opportunities  to connect with other healthcare industry professionals  
  • Ig certification credentialing for both immunoglobulin nurses and immunoglobulin pharmacists 
  • Resources including Ig standards, guidelines, and industry research 
  • IgNS conferences that educate and inform clinicians, patients, and the immunoglobulin community 

Advancing Ig Research and Education 

Through conferences and education, IgNS fosters collaboration between researchers and practicing clinicians. By focusing on sharing best practices and real-world data, IgNS helps shape the future of Ig therapy for conditions like myositis, multifocal motor neuropathy, primary immunodeficiency, and more.  

Improving the Patient Experience with Ig Therapy 

IgNS is committed to improving the patient experience with Ig therapy by standardizing training, sharing best practices, and highlighting patient-centered care so people receiving IVIg or SCIg therapy can get the most out of their treatment.  

CSI Pharmacy Partnership with IgNS 

As a nationwide provider of home infusion and specialty infusion pharmacy services, we’re proud to support IgNS’s commitment to bring standardized, compassionate care to patients receiving Ig therapy. Our team ensures we maintain best practices by partnering with IgNS and supporting events like the 2025 IgNS National Conference, so our patients receive the best care, backed by the highest standards in the field. 

Shaping the Future of Ig Therapy 

IgNS is playing an integral role in the continued success of Ig therapy by empowering healthcare professionals to stay educated, improving patient experiences, and advancing the field of infusion therapy. For patients and families dealing with rare or chronic conditions, IgNS helps ensure treatment is effective as well as delivered with expertise, compassion, and care.